For Patients

What is a clinical trial?
An introduction for patients and families

 

Clinical trials, sometimes called studies, are a form of research which involves people.
They are the final step in a long process that begins with research in a laboratory, and there are typically three phases in every clinical trial:

 

Three phases of a clinical trial

In Phase I, the new treatment is usually given at very low doses in the first instance, because the aim of this phase is primarily to examine how it affects the human body, to find a safe dose and to find how it should be delivered, although in cancer early signs of activity are hoped for.

A Phase I trial is usually fairly small, typically involving 15-30 patients.

In Phase II, the treatment’s effectiveness is studied as well as its side-effects.
Phase II trials involve a larger number of patients than Phase I, but typically it will be less than 100.

In Phase III, the safety and effectiveness of the new treatment is usually tested against an existing optimum treatment or recognised standard of care.

In a Phase III trial, patients are randomly allocated to the various treatment arms, in a process similar to throwing a dice, known as “randomisation.”

The study group is given the new treatment or procedure to be tested; the control group is given an existing optimum treatment which may or not include a placebo.

It is important to understand that patients cannot choose which group they will be allocated to, and that they may not receive the experimental treatment in the trial. Some may receive an inactive drug called a placebo, and this will be explained to you in the information sheet.

A Phase III trial, which typically involves hundreds if not thousands of patients, is a prerequisite for official approval of a new treatment in Europe as this is the only way to evaluate the effectiveness of the new treatment compared to existing treatments.

It should be noted that randomisation, typically associated with Phase III trials, is also increasingly used in Phase II trials.

 

Would you like to learn more?

Watch the webinar prepared by ENGOT leading experts for members of  ENGAGe (European Network of gynaecological Cancer Advocacy Groups). 

This webinar was held on Sept 2, 2019 as a part of ENGAGe-ENGOT Clinical Trial project. The plan of this project is to educate a number patients from major European countries to a level where they will be able to understand the process of a clinical trial and contribute with useful input from a patient perspective.

The more information you can find at engage.esgo.org

Up Coming ENGOT Meeting

ENGOT General Assembly

September 30 - October 1, 2021
Bernstorff Slot
Copenhagen, Denmark

Don't miss out on the latest updates and save the date!

You May Also Like

GCA6

GCA WORKSHOPS

Watch the Webcasts 

 

Read More

background

CLINICAL TRIALS

Latest Published Research

 

Read More

patient2

FOR PATIENTS

Key Insights

 

Read More

540x422

ESGO MEETING

ESGO 2021 Congress

Read More